Regional Biotechnology Conference

November 17, 2022 | USA

Regional Biotechnology
The Regional Biotechnology Conference is an annual conference that attracts more than 100 of the region’s movers and shakers for a half-day of dynamic speakers and topics that are important to start-up and early stage biotech company leaders.

Spotlight

UCB has formally opened its new biotechnology production unit in Bulle, Switzerland, one of the largest and most modern sites in Europe, which will enable an even better response to the needs of the hundreds of thousands of patients with severe diseases.


OTHER PAST CONFERENCES

Cell & Gene Meeting on the Mesa

October 11-13, 2022 | USA

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.

32nd Annual Conference of the European Society for Biomaterials

September 4-8, 2022 | France

It is my pleasure to welcome you to ESB2022, the 32nd Annual Conference of the European Society for Biomaterials (ESB), to be held between the 4th and the 8th of September 2022 in the beautiful and historical city of Bordeaux!

European Forum for the Industrial Biotechnology and the Bioeconomy

October 26-27, 2022 | Lithuania

26-27 October 2022, more than 500 industry leaders, SME representatives, policymakers and academia are expected in Vilnius, Lithuania to join Europe’s leading event on industrial biotechnology and the bioeconomy under the title ‘“Next generation economies: Industrial biotechnology for a sustainable society”.

BioProcess International Conference

September 27-30, 2022 | USA

Each year, BPI’s scientific agenda includes 200+ of the industry’s top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.

Spotlight

UCB has formally opened its new biotechnology production unit in Bulle, Switzerland, one of the largest and most modern sites in Europe, which will enable an even better response to the needs of the hundreds of thousands of patients with severe diseases.

resources